LLY
1,027.65
+0.36%↑
JNJ
199.6
+1.83%↑
ABBV
234.59
+0.96%↑
UNH
326.36
+1.55%↑
AZN
89.88
+0.83%↑
LLY
1,027.65
+0.36%↑
JNJ
199.6
+1.83%↑
ABBV
234.59
+0.96%↑
UNH
326.36
+1.55%↑
AZN
89.88
+0.83%↑
LLY
1,027.65
+0.36%↑
JNJ
199.6
+1.83%↑
ABBV
234.59
+0.96%↑
UNH
326.36
+1.55%↑
AZN
89.88
+0.83%↑
LLY
1,027.65
+0.36%↑
JNJ
199.6
+1.83%↑
ABBV
234.59
+0.96%↑
UNH
326.36
+1.55%↑
AZN
89.88
+0.83%↑
LLY
1,027.65
+0.36%↑
JNJ
199.6
+1.83%↑
ABBV
234.59
+0.96%↑
UNH
326.36
+1.55%↑
AZN
89.88
+0.83%↑
24h
Current
Min
4.23
Max
4.29
Recommendations | Buy |
|---|---|
12 Months Forecast | +130.77% upside |
By Acuity
84%
16%
350 / 374 Healthcare
Past performance is not a reliable indicator of future results.
24 Oct 2025, 13:04 UTC
Eli Lilly Agrees to Acquire Adverum Biotechnologies
DJ
Read
24 Oct 2025, 12:34 UTC
Eli Lilly Says Transaction Is Expected to Close in the 4Q >LLY
DJ
Read
24 Oct 2025, 12:34 UTC
Eli Lilly: Offer Also Includes 1 Non-Transferrable Contingent Value Right Entitling Holder to Receive Up to an Additional $8.91 Per CVR in Cash Upon the Achievement of 2 Milestones, for Total Potential Consideration of Up to $12.47/Shr >LLY
DJ
Read
24 Oct 2025, 12:33 UTC
Eli Lilly to Launch Tender Offer to Acquire All Outstanding Shares of Adverum for $3.56/Shr >LLY
DJ
Read
24 Oct 2025, 12:30 UTC
Lilly To Acquire Adverum Biotechnologies >LLY ADVM
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 9.9 USD 130.77%
High 30 USD
Low 4 USD
Based on 6 Wall Street analysts offering 12 month price targets forAdverum Biotechnologies Inc - Dist in the last 3 months.
By TipRanks
Buy
6 ratings
3
Buy
3
Hold
0
Sell
Based on 6 analysts giving stock ratings to Adverum Biotechnologies Inc - Dist in the past 3 months.
By Acuity
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
$